Author

May Khanna

NYU Langone HealthORCID 0000-0002-9989-6374Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Organism:rat· 2 Organism:human· 1 Research Focus:protein folding & dynamics· 1 Assay:protein structure· 1

Frequent Co-Authors

Rajesh KhannaiD· 3 shared Samantha Perez‐MilleriD· 3 shared Aubin MoutaliD· 2 shared Liberty François‐MoutaliD· 2 shared Shizhen LuoiD· 2 shared Aida Calderón‐RiveraiD· 1 shared Akash Rajaram· 1 shared Amol M. PatwardhaniD· 1 shared

Activity by Year

2019-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 34 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersNeuroscience

Rajesh KhannaORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Identifying interactions between TDP-43 N-terminal and RNA binding domains

David D. Scott, Lipsa Jena, Akash Rajaram, Jason Ang, Samantha Perez‐Miller, Vlad K. Kumirov, Rajesh Khanna, May Khanna

This study identifies interdomain interactions between the N-terminal and RNA binding domains of TDP-43 using NMR spectroscopy and computational modeling.

Protein Science · Sep 17, 2025Peer-reviewedBiophysics

Identification and targeting of a unique NaV1.7 domain driving chronic pain

Kimberly Gómez, Harrison J. Stratton, Paz Duran, Santiago Loya‐López, Cheng Wu Tang, Aida Calderón‐Rivera, Liberty François‐Moutal, May Khanna, Cynthia L. Madura, Shizhen Luo, Bryan D. Mckiver, Edward Choi, Dongzhi Ran, Lisa Boinon, Samantha Perez‐Miller, , Rajesh Khanna

The paper identifies a unique NaV1.7 domain that can be targeted to produce analgesia by disrupting its interaction with CRMP2.

Proceedings of the National Academy of Sciences · Jul 27, 2023Peer-reviewedNeuroscience

Targeting the CaV - interaction yields a selective antagonist of the N-type CaV2.2 channel with broad antinociceptive efficacy

Rajesh Khanna, Jie Yu, Xiao-Fang Yang, Aubin Moutal, Aude Chefdeville, Vijay M. Gokhale, Zunaira Shuja, Lindsey A. Chew, Shreya Sai Bellampalli, Shizhen Luo, Liberty François‐Moutal, Maria Serafini, Taehwan Ha, Samantha Perez‐Miller, Ki Duk Park, , May Khanna

The paper identifies a novel CaV2.2 channel antagonist with broad antinociceptive effects and reduced side effects in pain models.

Pain · Feb 5, 2019Peer-reviewedNeuroscience